Epidermal growth factor receptor (EGFR), another receptor tyrosine kinase, shows overexpression in up to 74% of bladder cancer specimens, as compared to the relatively low expression level seen in normal urothelium [125,126,127]. Here, EGFR is linked to urinary bladder carcinoma.